Caution Needed in Yew Cultivation Development: Don't Blindly Follow the Trend
After entering the 21st century, yew has been hyped up in some parts of China, with flyers everywhere exaggerating the benefits of growing yew to mythical proportions, claiming a "sky-high" profit of 100,000 yuan per 667 sq m. Tempted by the high returns, some kind-hearted investors were dazzled and rushed to invest in yew cultivation, and yew seemed to become a new project for getting rich overnight. In response, relevant experts in China remind: enterprises and farmers enthusiastic about investing in and developing yew cultivation need to be cautious. The true face of yew is as follows:
1. Exaggerating product uses. Some companies vigorously promote and hype, exaggerating the uses of yew and giving people the mistaken impression that yew can cure all painful conditions. In fact, paclitaxel extracted from yew is currently mainly used clinically to treat metastatic ovarian cancer and breast cancer, has certain efficacy against lung cancer, esophageal cancer and other cancers, and has not yet been found to have an effect on other cancers.
2. Exaggerating adaptability. Yew cultivation is not as widely adaptable as advertised, but has a certain range of adaptability. According to experts, China has 4 species and 1 variety, namely Taxus cuspidata, Taxus wallichiana, Taxus yunnanensis, Taxus chinensis and Taxus chinensis var. mairei. They are mainly distributed across 20 provinces (regions) from Heilongjiang in the north, to southern Gansu in the west, and to Tibet, Guangxi and northern Guangdong in the south, basically growing in mountainous areas at altitudes of 500-3,500 m, and are relatively suited to slightly acidic soil and humid climatic conditions; they cannot be introduced and planted just anywhere. Before introduction and planting, regional trials must be carried out, and large-scale introduction should only be done after confirming that they can grow normally and have cultivation value.
3. Exaggerating high returns. Many advertisements "boast" about return rates in the most fantastic terms, for example, some advertisements claim: "after planting for 5 years, 1 plant can sell for 80-100 yuan, more than 3,000 can be planted per 667 sq m of land, and the 5-year benefit is 240,000-300,000 yuan"; "the recovery price for dried branches and leaves is uniformly 90 yuan per kg"; "planting 0.66 ha of yew can extract 300-500 g of paclitaxel, sold at 3,000 USD per gram, yielding an income of 900,000-1,500,000 USD (equivalent to 7,380,000-12,300,000 yuan)"; "on-site purchase, with a deposit prepaid for the product." In reality, the 5-year benefit per 667 sq m is only a few tens of thousands of yuan.
4. Exaggerating paclitaxel content. Many companies' promotional materials boast that their yew is a new variety with a very high paclitaxel content. In fact, the paclitaxel content of different yew varieties differs greatly, and some varieties have very little. Even for the same variety, the paclitaxel content differs in different planting areas; some areas have high content, while in certain areas there is almost no paclitaxel or the content is so low that it has no extraction value.
5. Exaggerating market prospects. Industry insiders estimate that the theoretical annual demand for paclitaxel nationwide should be 500-1,000 kg. Because the price is too high, the actual domestic usage is only 1-2 kg. With the existing 333 ha of planting area, if development proceeds normally, domestic yew raw materials can basically meet production needs after 2-3 years. Therefore, advertisements exaggerating broad market prospects and claiming the market will not be saturated for decades are purely bait to lure people in.
6. The company has vanished. Yew companies everywhere often use the guise of "high-price recovery" and, after swindling the money, vanish. In March this year, when law enforcement personnel in Haidian District, Beijing conducted on-site inspections of 6 units in the district, they found that the people from the 6 companies were nowhere to be found. Many farmers invested money in these companies and ultimately lost everything.